2019 Speakers
Kate Adcock, Director Of Research And Innovation, The Muscular Dystrophy U.K.
Ion Agirrezabal, Senior Consultant, Covance Market Access And Phase Iv Solutions, Covance Market Access
Jeonghoon Ahn, Director, National Evidence-based Healthcare Collaborating Agency
John Alter, Vice President Pricing And Market Access, Pfizer
Mauricio Alvarez Reyes, Market Access Expert, Independent
Nusayba Anjarwalla, Engagement Manager, Global Pricing, Market Access And Analytics Line, Precision Xtract
Katerina Anokhina, Director, Medical Affairs, Uk And Ireland, Alexion Pharma UK
Diego Ardigo, Research And Development Rare Diseases Unit Head, Chiesi Farmaceutici SpA
Francis Arickx, Head Of The Directorate Reimbursement Of Medicines And Pharmaceutical Policy, National Institute for Health and Disability Insurance RIZIV-INAMI
Nadeem Ashraf, Medical Advisor - Diabetes, N/A
Matthew Bending, Senior Principal And Executive Director Of Hta Strategy, Market Access Consulting, Evidera
Michael Blackney, Director, Covance
Inge Bliestle, Chief Operating Officer, TolerogenixX
Axel Boehnke, Director Market Access (Global Responsibility), PTC Therapeutics
Luc Boileau, Chairman and Chief Executive Officer, Inesss
Pedro Borga, Consultant, Lifescience Dynamics Ltd
Carole Bradley-Kennedy, Head Of Market Access, Boehringer Ingelheim Canada
Hassan Bruneo, Associate Director, Alnylam Switzerland Gmbh
Anna Bucsics, Project Advisor, Mechanism of Coordinated Access to orphan medicinal products (MoCA)
Abbes Cadi-Tazi, Consultant, Lifescience Dynamics Ltd
Hector Castro, Senior Technical Director- Pharmaceutical Economics And Financing, Management Science For Health
Nicki Catterick-Kang, Head Of Pricing Uk And Ireland, Merck Group
Anjan Chatterjee, Global Head Of Real World Evidence, Boehringer Ingelheim Pharma GmbH & Co. KG
Deven Chauhan, Senior Director, Value Evidence Leader, GlaxoSmithKline
Sania Chouman, Global Market Access Lead, Takeda
Francis Crawley, Executive Director, Strategic Initiative For Developing Capacity In Ethical Review (Sidcer), Good Clinical Practice Alliance (GCPA)
Don Creighton, Managing Director, Huron
Alan Crowther, General Manager, Global Pricing And Access Solutions, EVERSANA
Omar Dabbous, Vice President Health Economics And Outcomes Research, AveXis
Charles De Cidrac, Director Of Health Insurance, AXA
Carla Deakin, Programme Director - Commercial And Managed Access, NICE
Stephen Deitch, Vice President, C.R.A. Charles River Associates
Brenda Dooley, Founder And Chief Executive Officer, Axis Consulting
Rudy Dupree, Senior Project Manager, Zorginstituut
Jenny Ebert, National Account Director, Genzyme Sanofi Corp
Jane Erickson, Vice President, Covance Market Access And Phase Iv Solutions, Covance Market Access
Michael Ermisch, Specialist, Department Of Pharmaceuticals, G.K.V. Spitzenverband
Valerie Faillat, Head Of Sanofi Espoir Foundation, Sanofi
Diar Fattah, Associate Director Of Medicines Optimisation, N.H.S._Dartford Gravesham and Swanley C.C.G.
Martina Flammer, Senior Vice President, Head Of Corporate Customer Value, Boehringer-Ingelheim
Taro Fujimoto, External Affairs Associate And Market Access, Bayer Pharmaceuticals
Oliver Gassner, Head Digital Health Intelligence | Emea, Bayer
Ivan Glushkov, External Affairs Department Director, S.T.A.D.A.
Josie Godfrey, Independent, Duchenne
Wim Goettsch, Director of EUnetHTA JA3, Zorginstituut
Mohamed Hamada, Independent, Independent
Camille Harfouche, Regional Office Lead, Algorithm
Adam Heathfield, Senior Director of Global Health And Value Innovation Centre, Pfizer Ltd
Andrew Hobbs, Managing Director, Huron Consulting Group
Birgit Holz, Global Head Of Contracting Innovation, Sanofi
Patrick Hopkinson, Executive Director, Wwheor Markets, Bristol-Myers Squibb
Lucy Hoppe, Clinical Effectiveness Manager (Evidence Synthesis) In The Clinical Effectiveness Team, Bupa
Nigel Hughes, Scientific Director, RMEDS Quantitative Sciences,, Janssen
Wills Hughes-Wilson, Head Of Patient Access And Commercial Planning, Mereo BioPharma
Kankendria Ingram, Independent, Independent
Dawn Ireland, President, CDH International
Daniel Jackson, Global Head Of Market Access, Solutions And Strategy, UCB
David Jakouloff, Global Head Of Market Access, Dmd, PTC Therapeutics
Saira Jan, Director Of Pharmacy Strategy And Clinical Integration, Blue Cross Blue Shield of New Jersey
Rosemary Jose, Director And Commercial Lead, Strategic Market Access, Pharmerit International
Navin Joshi, Global Head Of Pricing And Access Capabilities, GlaxoSmithKline
Marcela Junqueira, Head Of Strategic Affairs And Health Economics, Janssen Pharmaceutical
Basmah Khogeer, Engagement Manager, Global Pricing, Market Access And Analytics, Precision Xtract
Diane Kleinermans, Advisor To The Ministry Of Health And Social Affairs, Belgian Federal Government
Alison Kneen, Vice President, Global Access Advisory, DRG Abacus
Jolanda Koenders, Head Of Pricing And Market Access Pharma, Novartis
Akshay Kumar, Senior Director, Huron Consulting Group
Adam Kundzewicz, Senior Global Payer Strategy Manager, Head Of Pricing, Boehringer Ingelheim Pharma GmbH & Co. KG
Marie-Liesse Le Corfec, Global Portfolio Marketing Head, Ps, B.D. Pharmaceuticals Systems
Oliver Leatham, Global Head Of Value & Access, Certara
Giovanny Leon, Pricing And Market Access Director For Latin America And Canada, Novartis Ag
Sandy Leonard, Vice President Of Medical Evidence And Observational Research, AstraZeneca
Friedhelm Leverkus, Director Health Technology Assessment And Outcomes Research, Pfizer
Herve Lilliu, Chief Executive Officer, inbeeo
Sune Lindgaard, Chief Of Business Intelligence, Amgros, Denmark
Qing Liu, Head Of Biostatistics And Data Management, Amicus Therapeutics Inc
Catarina Lopes Pereira, Market Access Manager, Medicines for Europe
Francois Lucas, Senior Director, Huron Consulting Group
Elena Lungu, Manager Of Policy Development, Government of Canada (Canada)
Mark Macgregor, Co-Vice Chair, Scottish Medicines Consortium, Nhs Scotland
Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway
Joerg Mahlich, Head Heor, Janssen Pharmaceutical K.K.
Andrea Mantovani, Market Access Expert, Independent
Eva Marchese, Vice President, C.R.A. Charles River Associates
Anne Marciniak, Head Of Market Access, Europe, Aimmune
Alen Marijam, Heor Senior Manager, Em, GlaxoSmithKline
Kevin Mayo, Head, Global Market Access - New Products, Shire Pharmaceuticals
Elizabeth Mckenna, Head Of Market Access Uk And Ireland, Vertex Pharmaceuticals
Paul Mcloughlin, Vice President Of Market Access & Phase Iv Solutions, Covance
Soniya Mokashi, Global Senior Medical Affairs Physician, Norgine
Patrick Mollon, Former Director Gheore, Ipsen Pharma
Tal Morginstin, Director, Nlhs (National List Of Health Services) Assessment Division, Ministry of Health
Thomas Mueller, Head Of Directorate General 1 "Drugs, Medical Devices, Biotechnology", Federal Ministry of Health Germany
Diane Munch, Head Of Global Pricing, Patient And Health Impact, Pfizer
Sue Naeyaert, Vice President Global Government Affairs, Policy And Pharmacoeconomics Biosimilars, Fresenius Kabi
Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)
Elsa Navarro, Senior Advisor, Evidera
Waldemar Ockert, Director, Rwi Business Market Analytics, Astellas Pharma
Irina Odnoletkova, Vice President Health Technology Assessment, Apogenix Gmbh
Laura O'Hanlon, Associate Director, International Market Access/Reimbursement, Myriad genetics
Vitaly Omelyanovskiy, General Director, Center Of Healthcare Quality Assessment And Control, Federal State Budgetary Institution, the Center for Healthcare Quality Assessment and Control of the Ministry of Health of the R
Nneka Onwudiwe, Founder And Chief Executive Officer, Pharmacoeconomics Consultants of America
Mario Ouwens, Statistical Science Director, Astra Zeneca
Melissa Paige, Uva Cancer Center, Oncology Patient Access Principal Coordinator, Patient Advocate, U.V.A. Health System
Ana Palma, Senior Director Global Hta And Patient Access Lead, Sobi
Elena Panitti, Global Rwe Capability Building Lead, Novartis
Detlev Parow, Head Pharmaceutical Department, D.A.K.
Chris L Pashos, Vice President Of Global Evidence Strategy, AbbVie
Geert Pelsmaeker, General Manager, Leaphy
Marco Penske, Head Of Market Access And Health Care Affairs, Boehringer-Ingelheim
Dan Pettitt, Vice President Immunology Market Access And Policy Global Commercial Strategy Organization, Janssen Pharmaceuticals
Ed Pezalla, Former Vice President, National Medical Director For Pharmaceutical Policy And Strategy, Aetna
Andres Pichon Riviere, Executive Director And Director Of Health Technology Assessment And Economic Evaluations, I.E.C.S.
Lara Pippo, Head Of Market Access, C.S.L. Behring Spa
Adam Plich, Former Vice President, Head Of Pricing And Market Access Europe, Plich Advisory
Angelina Irizari Policarpio, Head Of Us Heor Field Team And Us Quality, Boehringer Ingelheim
Robert Popovian, Vice President Of Government Relations, Pfizer
Diann Potestio, Vice President Market Access, Ascendis Pharma
Rafaat Rahmani, President, Lifescience Dynamics Ltd
Marco Rauland, Vice President, Map Gmande And Training Academy, Global Market Access And Pricing, Biopharma| Global Operations, Merck Group
S Ravetkar, Executive Director, Serum Institute of India Ltd
Ajan Reginald, Chief Executive Officer, Celixir
Andreia Ribeiro, Engagement Manager, Lifescience Dynamics Ltd
Giuseppe Rosano, Member Of The Cardiovascular Working Party, European Medicines Agency
Katja Rudell, Honorary Research Fellow, Queen Mary University of London
Igor Rudychev, Senior Director, Business Insights, AstraZeneca
Emily Saadi, Senior Undergraduate, Health Care Policy And Management, Georgetown University
Ryan Saadi, Vice President, Global Market Access, CSL Behring
Steve Sandor, Vice President, Market Access And Trade, Paratek Pharmaceuticals , Inc.
Gustavo Saraiva Dos Anjos, Head Of Market Access, Respiratory Pipeline, GlaxoSmithKline
Gundula Schneidewind, Head Ethics And Compliance, Europe And Canada, Takeda
Michael Schroter, Partner, Viopas Partners
Ad Schuurman, Senior Advisor International Affairs, National Health Care Institute (ZIN), the Netherlands
Ayman Semaan, Head Of Market Access, Algorithm
Simon Shohet, Senior Director, Global Market Access And Pricing, Ipsen
Tamir Singer, Head Of Commercial Development, Specialised Commissioning, NHS England
Anindita Sinha, Director, Global Market Access, Pfizer
Matt Slabbert, Head Of Market Access, Advocacy And Policy, Anz, Bayer Pharmaceuticals
Jan Span, Member Of The Cross-Committee Task Force On Registries And Senior Clinical Assessor, Medicines Evaluation Board The Netherlands
Anastasiya Stepanova, State Authorities Manager, JSC Nizhpharm
Richard Stephens, Chair Of Consumer Liaison Group, National Cancer Research Institute (NCRI)
Simon Swift, Managing Director, Methods Analytics
Bertrand Tardivel, General Manager, Frehel GmbH
Renske Ten Ham, Phd Candidate, Utrecht University
Gwilym Thompson, Director Worldwide Heor, BMS
David Thompson, Senior Vice President, Head Of Thought Leadership, Real World And Late Phase Research, Syneos Health
Daria Tolkacheva, Head Of Health Economics, JSC BIOCAD
Jorg Tomeczkowski, Head Of Market Access, Janssen Cilag Germany
Keiko Tone, Vice President Global Market Access, Shionogi Inc
Ariella Toren, Director Of Medicine And Medical Technologies, Hmos Department, Israel - Ministry Of Health
Dr Josep Torrent-Farnell, Medicines Department, Catalan Health Service
Sheela Upadhyaya, Associate Director Hst, National Institute for Health and Care Excellence
Bart Van Den Daele, Head of External Affairs – Director Market Access, Gilead Sciences Belgium Bvba
Goedele Van Haasteren, Hta Specialist, Swiss Federal Office of Public Health
Christina Vandoros, Director, Macroeconomics & Health Policy - Emea, Janssen
Kart Veliste, Chief Specialist At Department Of Medicines And Medical Devices, Haigekassa Estonia
Jaume Vidal, Policy Advisor, Eu Projects, Health Action International
Reg Waldeck, Market Access Strategy Leader, Bayer Corp
Amy Wang, Life Sciences Consultant, Navigant
David Watson, Director Pricing And Reimbursement, ABPI
Lindsay Weaver, Executive Director, Children Living With Inherited Metabolic Diseases
Meike Wenzel, Partner, Executive Insight Healthcare Consultants
David Williams, Chief Medical Officer, Visformatics
x x, Business Development, Vistex
Entela Xoxi, Former Aifa, Universita Cattolica Del Sacro Cuore
Fabrizio Zucca, Director Patient Access Dach, Sobi
Contact us
To sponsor or exhibit:
Edmond Rama
+44 (0)207 092 1052
edmond.rama@terrapinn.com
To speak:
Chris Shanks
+44 (0)207 092 1151
chris.shanks@terrapinn.com
Organiser
